The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Buprenorphine vs Methadone Maintenance Treatment for Concurrent Opioid Dependence and Cocaine Abuse
Abstract
BACKGROUND: Buprenorphine, a partial mu-agonist and kappa-antagonist, has been proposed as an alternative to methadone for maintenance treatment of opioid dependence, especially for patients with concurrent cocaine dependence or abuse. This study evaluated whether higher maintenance doses of buprenorphine and methadone are superior to lower doses for reducing illicit opioid use and whether buprenorphine is superior to methadone for reducing cocaine use. METHODS: A total of 116 subjects were randomly assigned to 1 of 4 maintenance treatment groups involving higher or lower daily doses of sublingual buprenorphine (12 or 4 mg) or methadone (65 or 20 mg) in a double-blind, 24-week clinical trial. Outcome measures included retention in treatment and illicit opioid and cocaine use as determined by urine toxicology testing and self-report. RESULTS: There were significant effects of maintenance treatment on rates of illicit opioid use, but no significant differences in treatment retention or the rates of cocaine use. The rates of opioid-positive toxicology tests were lowest for treatment with 65 mg of methadone (45%), followed by 12 mg of buprenorphine (58%), 20 mg of methadone (72%), and 4 mg of buprenorphine (77%), with significant contrasts found between 65 mg of methadone and both lower-dose treatments and between 12 mg of buprenorphine and both lower-dose treatments. CONCLUSIONS: The results support the superiority of higher daily buprenorphine and methadone maintenance doses vs lower doses for reducing illicit opioid use, but the results do not support the superiority of buprenorphine compared with methadone for reducing cocaine use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Design and Analysis: A Researcher's Handbook
Beaton, A. E., & Keppel, G. (1975) · American Educational Research Journal · doi:10.2307/1162588 · Cited by 5,822
The fifth edition of the addiction severity index
McLellan, A. T., Kushner, H., Metzger, D., Peters, R., Smith, I., Grissom, G., Pettinati, H., & Argeriou, M. (1992) · Journal of Substance Abuse Treatment · doi:10.1016/0740-5472(92)90062-s · Cited by 4,222
Basic and Clinical Biostatistics,
(2002) · Survey of Ophthalmology · doi:10.1016/s0039-6257(02)00360-0 · Cited by 1,809
The Effectiveness of Methadone Maintenance Treatment: Patients, Programs, Services, and Outcome
Ball, J. C., & Ross, A. O. (1991) · Cited by 903
The Effects of Psychosocial Services in Substance Abuse Treatment
McLellan, A. T. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03500150065028 · Cited by 869
Statistical Analysis of Epidemiologic Data
Selvin, S. (2004) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195172805.001.0001 · Cited by 822
Incentives Improve Outcome in Outpatient Behavioral Treatment of Cocaine Dependence
Higgins, S. T. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950070060011 · Cited by 806
Jasinski, D. R. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770280111012 · Cited by 782
Clinical pharmacology of buprenorphine: Ceiling effects at high doses
Walsh, S. L., Preston, K. L., Stitzer, M. L., Cone, E. J., & Bigelow, G. E. (1994) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1994.71 · Cited by 773
Gibbons, R. D. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820210073009 · Cited by 719
Cocaine Use and HIV Infection in Intravenous Drug Users in San Francisco
Chaisson, R. E. (1989) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1989.03420040099027 · Cited by 587
A Controlled Trial of Buprenorphine Treatment for Opioid Dependence
Johnson, R. E. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03480200058024 · Cited by 572
Silverman, K. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830050045007 · Cited by 379
A Controlled Trial Comparing Buprenorphine and Methadone Maintenance in Opioid Dependence
Ling, W. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830050035005 · Cited by 366
Comparison of buprenorphine and methadone in the treatment of opioid dependence
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.7.1025 · Cited by 305
Buprenorphine suppresses heroin use by heroin addicts
Mello, N. K., & Mendelson, J. H. (1980) · Science · doi:10.1126/science.7352279 · Cited by 298
Acute administration of buprenorphine in humans: partial agonist and blockade effects.
Walsh, S. L., Preston, K. L., Bigelow, G. E., & Stitzer, M. L. (1995) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10510-7 · Cited by 283
Buprenorphine versus Methadone Maintenance for Opioid Dependence
KOSTEN, T. R., SCHOTTENFELD, R., ZIEDONIS, D., & FALCIONI, J. (1993) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199306000-00004 · Cited by 267
Self-citationImplications of Methadone Maintenance for Theories of Narcotic Addiction
Dole, V. P. (1988) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1988.03410200081030 · Cited by 240
Variations in methadone treatment practices. Results from a national study
D’Aunno, T. A. (1992) · JAMA · doi:10.1001/jama.267.2.253 · Cited by 230
Buprenorphine: dose-related blockade of opioid challenge effects in opioid dependent humans.
Bickel, W. K., Stitzer, M. L., Bigelow, G. E., Liebson, I. A., Jasinski, D. R., & Johnson, R. E. (1988) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20047-7 · Cited by 226
The metabolism and excretion of buprenorphine in humans.
Cone, E. J., Gorodetzky, C. W., Yousefnejad, D., Buchwald, W. F., & Johnson, R. E. (1984) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)07765-7 · Cited by 225
Dose-Response Effects of Methadone in the Treatment of Opioid Dependence
Strain, E. C., Stitzer, M. L., Liebson, I. A., & Bigelow, G. E. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-1-199307010-00004 · Cited by 224
Fudala, P. J., Jaffe, J. H., Dax, E. M., & Johnson, R. E. (1990) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1990.67 · Cited by 191
A 2.5-Year Follow-up of Cocaine Use Among Treated Opioid Addicts: Have Our Treatments Helped?
Kosten, T. R. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800150101012 · Cited by 182
Heroin use during methadone maintenance treatment: the importance of methadone dose and cocaine use.
Hartel, D. M., Schoenbaum, E. E., Selwyn, P. A., Kline, J., Davenny, K., Klein, R. S., & Friedland, G. H. (1995) · American Journal of Public Health · doi:10.2105/ajph.85.1.83 · Cited by 169
Buprenorphine Suppresses Cocaine Self-Administration by Rhesus Monkeys
Mello, N. K., Mendelson, J. H., Bree, M. P., & Lukas, S. E. (1989) · Science · doi:10.1126/science.2772637 · Cited by 165
Buprenorphine effects on human heroin self-administration: an operant analysis.
Mello, N. K., Mendelson, J. H., & Kuehnle, J. C. (1982) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)33287-8 · Cited by 157
Cocaine use by clients in methadone programs: Significance, scope, and behavioral interventions
Condelli, W. S., Fairbank, J. A., Dennis, M. L., & Rachal, J. V. (1991) · Journal of Substance Abuse Treatment · doi:10.1016/0740-5472(91)90040-h · Cited by 155
Buprenorphine has potent kappa opioid receptor antagonist activity
LEANDER, J. (1987) · Neuropharmacology · doi:10.1016/0028-3908(87)90112-2 · Cited by 140
Treatment of cocaine abuse with buprenorphine
Kosten, T. R., Kleber, H. D., & Morgan, C. A. (1989) · Biological Psychiatry · doi:10.1016/0006-3223(89)90090-5 · Cited by 129
Effects of buprenorphine and methadone in methadone-maintained subjects
WALSH, S. L., June, H. L., Schuh, K. J., Preston, K. L., Bigelow, G. E., & Stitzer, M. L. (1995) · Psychopharmacology · doi:10.1007/bf02246290 · Cited by 124
Role of opioid antagonists in treating intravenous cocaine abuse
Kosten, T. R., Kleber, H. D., & Morgan, C. (1989) · Life Sciences · doi:10.1016/0024-3205(89)90589-4 · Cited by 124
Schottenfeld, R. S., Pakes, J., Ziedonis, D. M., & Kosten, T. R. (1993) · Biological Psychiatry · doi:10.1016/0006-3223(93)90258-f · Cited by 118
Self-citationBrown, E. E., Finlay, J. M., Wong, J. T., Damsma, G., & Fibiger, H. C. (1990) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23126-3 · Cited by 112
Buprenorphine versus methadone in the treatment of opioid-dependent cocaine users
Strain, E. C., Stitzer, M. L., Liebson, I. A., & Bigelow, G. E. (1994) · Psychopharmacology · doi:10.1007/bf02247469 · Cited by 108
Winger, G. D., Skjoldager, P. D., & Woods, J. H. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10977-4 · Cited by 108
A treatment crisis: Cocaine use by clients in methadone maintenance programs
Kolar, A. F., Brown, B. S., Weddington, W. W., & Ball, J. C. (1990) · Journal of Substance Abuse Treatment · doi:10.1016/0740-5472(90)90005-b · Cited by 106
Personality Disorders and Treatment Outcome in Methadone Maintenance Patients
Cacciola, J. S., Rutherford, M. J., Alterman, A. I., McKay, J. R., & Snider, E. C. (1996) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199604000-00006 · Cited by 105
Antecedents and Consequences of Cocaine Abuse among Opioid Addicts
Kosten, T. R., Rounsaville, B. J., & Kleber, H. D. (1988) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-198803000-00006 · Cited by 88
Buprenorphine treatment of opioid dependence: clinical trial of daily versus alternate-day dosing
Johnson, R. E., Eissenberg, T., Stitzer, M. L., Strain, E. C., Liebson, I. A., & Bigelow, G. E. (1995) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(95)01189-7 · Cited by 86
A Preliminary Investigation of Outcome Following Gradual or Rapid Buprenorphine Detoxification
Amass, L., Bickel, W. K., Higgins, S. T., & Hughes, J. R. (1995) · Journal of Addictive Diseases · doi:10.1300/j069v13n03_04 · Cited by 83
HIV infection and cocaine use in methadone maintained and untreated intravenous drug users
Meandzija, B., O’Connor, P. G., Fitzgerald, B. J., Rounsaville, B. J., & Kosten, T. R. (1994) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(94)90092-2 · Cited by 79
Effects of buprenorphine and naltrexone on reinstatement of cocaine-reinforced responding in rats.
Comer, S. D., Lac, S. T., Curtis, L. K., & Carroll, M. E. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39443-7 · Cited by 73
Methadone Treatment and the Acquired Immunodeficiency Syndrome Epidemic
Dole, V. P. (1989) · JAMA · doi:10.1001/jama.1989.03430120135037 · Cited by 72
Buprenorphine effects in methadone-maintained volunteers: effects at two hours after methadone.
Strain, E. C., Preston, K. L., Liebson, I. A., & Bigelow, G. E. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24449-4 · Cited by 70
Effects of buprenorphine on self-administration of cocaine and a nondrug reinforcer in rats
Carroll, M. E., & Lac, S. T. (1992) · Psychopharmacology · doi:10.1007/bf02244812 · Cited by 58
Buprenorphine-Background to Its Development as a Treatment for Opiate Dependence
Lewis, J. W., & Walter, D. S. (1992) · PsycEXTRA Dataset · doi:10.1037/e496132006-003 · Cited by 57
Evaluation of TDx Cocaine Metabolite Assay
Poklis, A. (1987) · Journal of Analytical Toxicology · doi:10.1093/jat/11.5.228 · Cited by 54
Assessment and management of opioid withdrawal symptoms in buprenorphine‐dependent subjects
Luis, S. A. N., Camı́, J., FERNÁNDEZ, T., OLLE, J. M., PERI, J. M., & Torrens, M. (1992) · British Journal of Addiction · doi:10.1111/j.1360-0443.1992.tb01900.x · Cited by 53
Predicting Cocaine Use Among Methadone Patients: Analysis of Findings From a National Study
Dunteman, G. H., Condelli, W. S., & Fairbank, J. A. (1992) · Psychiatric Services · doi:10.1176/ps.43.6.608 · Cited by 50
Development of uterine adenomyosis after treatment with dopamine antagonists in mice
Singtripop, T., Mori, T., Kyun, P. M., Sakamoto, S., & Kawashima, S. (1991) · Life Sciences · doi:10.1016/0024-3205(91)90004-u · Cited by 48
Changes in Cocaine Use After Entry to Methadone Treatment
Magura, S., Siddiqi, Q., Freeman, R. C., & Lipton, D. S. (1991) · Journal of Addictive Diseases · doi:10.1300/j069v10n04_03 · Cited by 47
Effects of single and multiple intravenous cocaine injections in humans maintained on methadone.
Foltin, R. W., Christiansen, I. S., LEVIN, F. R., & Fischman, M. W. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12060-0 · Cited by 45
Kajiwara, M., Aoki, K., ISHII, K., Numata, H., Matsumiya, T., & Oka, T. (1986) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.40.95 · Cited by 40
Carroll, M. E., Carmona, G. N., May, S. A., Buzalsky, S., & Larson, C. M. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10970-1 · Cited by 40
Opioid agonist and antagonist behavioural effects of buprenorphine
Leander, J. D. (1983) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1983.tb09410.x · Cited by 39
Phenomenology and neurobiology of social phobia: comparison with panic disorder.
Uhde, T. W., Tancer, M. E., Black, B., & Brown, T. M. (1991) · PubMed · Cited by 37
Hunt, D., Spunt, B. J., Lipton, D. S., Goldsmith, D. S., & Strug, D. L. (1986) · Advances in Alcohol & Substance Abuse · doi:10.1300/j251v06n02_08 · Cited by 36
Mendelson, J. H., TEOH, S. K., Mello, N. K., & Ellingboe, J. (1992) · PubMed · Cited by 35
Buprenorphine Effects on Morphine- and Cocaine-Induced Subjective Responses by Drug-Dependent Men
TEOH, S. K., Mello, N. K., Mendelson, J. H., et al. (1994) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199402000-00003 · Cited by 30
Cocaine Use in Persons on Methadone Maintenance
Hanbury, R., Sturiano, V., Cohen, M. J., et al. (1986) · Advances in Alcohol & Substance Abuse · doi:10.1300/j251v06n02_07 · Cited by 25
Buprenorphine suppresses cocaine self-administration in rhesus monkeys.
Mello, N. K., Mendelson, J. H., Bree, M. P., & Lukas, S. E. (1989) · PubMed · Cited by 24
Development of Buprenorphine for the Treatment of Opioid Dependence
Johnson, R. E., & Fudala, P. J. (1992) · PsycEXTRA Dataset · doi:10.1037/e496132006-009 · Cited by 15
Effects of Acute Buprenorphine on Responses to Intranasal Cocaine: A Pilot Study
Rosen, M. I., Pearsall, H. R., McDougle, C. J., Price, L. H., Woods, S. W., & Kosten, T. R. (1993) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952999309001634 · Cited by 13
Strain, E. C., Preston, K. L., Stitzer, M. L., Liebson, I. A., & Bigelow, G. E. (1994) · American Journal on Addictions · doi:10.3109/10550499409117246 · Cited by 8
Improving access to primary care
Alper, P. (1993) · JAMA · doi:10.1001/jama.269.15.1943b · Cited by 3
Cited by
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002207.pub4 · Cited by 2,274
Linehan, M. M., Dimeff, L. A., Reynolds, S. K., Comtois, K. A., Welch, S. S., Heagerty, P., & Kivlahan, D. R. (2002) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(02)00011-x · Cited by 741
A Comparison of Levomethadyl Acetate, Buprenorphine, and Methadone for Opioid Dependence
Johnson, R. E., Chutuape, M. A., Strain, E. C., Walsh, S. L., Stitzer, M. L., & Bigelow, G. E. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011023431802 · Cited by 623
Eap, C. B., Buclin, T., & Baumann, P. (2002) · Clinical Pharmacokinetics · doi:10.2165/00003088-200241140-00003 · Cited by 599
Amato, L., Davoli, M., A.Perucci, C., Ferri, M., Faggiano, F., & P. Mattick, R. (2005) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2005.02.007 · Cited by 567
Metadata
- Authors
- Schottenfeld, R. S.
- Venue
- Archives of General Psychiatry
- Publisher
- American Medical Association (AMA)
- Published
- 1997-08-01
- Volume
- 54
- Issue
- 8
- Pages
- 713
- ISSN
- 0003-990X (ISSN-L)
- OpenAlex
- W2121153184
- Cited by
- 303
- References
- 67
- FWCI
- 18.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.